Under construction – not a live service
Sign in
Taking people in ItalyNo phase

Measuring Resting Energy Use in Children With Crohn's Disease and Ulcerative Colitis

Measures how much energy the body uses at rest in children with bowel inflammation.

Plain-language title generated from the registry record
Registry title: Resting Energy Expenditure in Pediatric Patients With Inflammatory Bowel Disease (REE-MICI)

Key facts

Where
Alessandria, ItalySee the site

AI summary: who the study is looking for

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for children and teenagers newly diagnosed with Crohn's disease or ulcerative colitis. It measures how much energy their body uses at rest.

Age
6 to 17 years
Sex
All sexes can join.
Disease stage
New diagnosis of inflammatory bowel disease (Crohn disease or ulcerative colitis), based on ECCO/ESPGHAN criteria.
Earlier treatment
No intestinal surgery and no parenteral or enteral nutrition in the 6 weeks before the first evaluation.

Main reasons for not taking part

  • Intestinal surgery within 6 weeks before the first evaluation
  • Parenteral or enteral nutrition within 6 weeks before the first evaluation
  • Eating disorders
  • Other chronic diseases that may cause malabsorption

Read by machine on 12 November 2026.

Could this be for you?

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 6 and 17 years old?

Source: NCT07670975, who can take part

Where in Italy

  • Pediatric UnitAlessandria, ItalyContact: Clinical Trial CenterTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Trial details

Who runs it
Azienda Ospedaliera SS. Antonio e Biagio e Cesare Arrigo di Alessandria
Trial code
NCT07670975
Record updated
26 June 2026
Original description
This multicenter prospective observational non-pharmacological study aims to evaluate resting energy expenditure (REE) in pediatric patients affected by inflammatory bowel disease (IBD), including Crohn's disease and ulcerative colitis. REE will be measured using indirect calorimetry and estimated using predictive equations. The study also aims to investigate the relationship between REE, disease activity, and dietary or pharmacological treatments. Clinical, laboratory, anthropometric, nutritional, and disease activity data will be collected during routine clinical follow-up at diagnosis, after induction therapy, and during follow-up visits.Read full original descriptionShow less

Measurement of Basal Metabolism in Patients With Crohn's Disease and Ulcerative Colitis and Correlation With Disease Activity.

This multicenter prospective observational non-pharmacological study aims to evaluate resting energy expenditure (REE) in pediatric patients affected by inflammatory bowel disease (IBD), including Crohn's disease and ulcerative colitis. REE will be measured using indirect calorimetry and estimated using predictive equations. The study also aims to investigate the relationship between REE, disease activity, and dietary or pharmacological treatments. Clinical, laboratory, anthropometric, nutritional, and disease activity data will be collected during routine clinical follow-up at diagnosis, after induction therapy, and during follow-up visits.

Inclusion: Pediatric patients aged 6 to 17 years; New diagnosis of inflammatory bowel disease, including Crohn disease or ulcerative colitis, according to ECCO/ESPGHAN criteria; Written informed consent signed by parents or legal guardians.

Exclusion: Intestinal surgery within 6 weeks before the first evaluation; Parenteral or enteral nutrition within 6 weeks before the first evaluation; Eating disorders or other chronic diseases associated with possible malabsorption.

ClinicalTrials.gov NCT07670975